Business Standard

SPARC back in the black in Q1, reports profit of Rs 57 cr; stock jumps 14%

It's revenue from operations for the quarter under review came in at Rs 185.45 crore, clocking a growth of 970.73 per cent YoY from Rs17.32 crore reported in Q1FY20

The company's net profit in Q1FY21 came in at Rs 56.69 crore, compared with a loss of Rs 94.19 crore in the year-ago quarter
Premium

SPARC's sister firm, Sun Pharma, too, was trading 1 per cent higher at Rs 534 apiece on the BSE

SI Reporter New Delhi
Shares of SPARC (Sun Pharma Advanced Research Company) zoomed 14.5 per cent to Rs 200 apiece on the BSE on Wednesday after the company declared healthy June quarter results on Tuesday, post market hours. At 9:34 am, the stock was ruling 10.6 per cent higher at Rs 193.2 on the BSE, as against 343 points, or 0.9 per cent, rally in the benchmark S&P BSE Sensex.

The company's net profit in Q1FY21 came in at Rs 56.69 crore, compared with a loss of Rs 94.19 crore in the year-ago quarter. It's EBITDA stood at Rs 60.78 crore, as against a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in